Pharmaceutical News

RSS

Older antibiotic shows success in treating drug-resistant TB in small study

"An antibiotic used to treat severe bacterial infections showed promise at treating a highly drug-resistant and deadly form of tuberculosis [TB]," according to a study conducted by U.S. government and South Korean researchers and published in the New England Journal of Medicine on Wednesday, Reuters reports (Steenhuysen, 10/17).

20 Oct 2012

R848 chemical can prime the immune system to fight lymphoma

UK scientists hope that lymphoma patients could benefit from a new drug that triggers the cancer-fighting properties of the body's own immune system, after highly promising early laboratory results.

From The University of Manchester 20 Oct 2012

Most compounding pharmacies are not accredited

News outlets, following the story about a deadly meningitis outbreak linked to drugs provided by a compounding pharmacy, explore the issue of accreditation, how many more people are at risk and what leads doctors to use these drugs.

20 Oct 2012

Combination of medication and behavioral therapy improves smoking cessation rates

Smokers who try to quit would be more successful if they combined medication or nicotine-replacement therapy with behavioral counseling, finds a new review in The Cochrane Library. Few lifestyle changes deliver as many positive health benefits as quitting smoking, including improved circulation, lowered blood pressure and a decreased risk of cancer and heart disease.

20 Oct 2012

Shingles vaccine reduces risk of herpes zoster disease in older patients

Older adults who get the shingles vaccine have a nearly 50 percent reduced risk of developing the often debilitating disease, finds a new evidence review from The Cochrane Library.

20 Oct 2012

High flavonoid intake may reduce risk of highly aggressive prostate cancer

A study by Susan Steck of the Arnold School of Public Health finds that a high intake of flavonoids, a group of compounds found in plants, may lower the risk for highly aggressive prostate cancer.

20 Oct 2012

Sanofi Pasteur files Fluzone sBLA with FDA for treatment of influenza

Sanofi Pasteur, the vaccines division of Sanofi, announced today that it has filed a Supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) for a quadrivalent formulation of its Fluzone (Influenza Virus Vaccine).

20 Oct 2012

True scale of anti-psychotic usage in dementia may be under-estimated

The scale of the challenge to reduce the use of anti-psychotic drugs by people with dementia may be under-estimated, according to researchers from Aston University and the University of East Anglia, working with NHS Kent and Medway. There is a key public health challenge to reduce the prescribing of anti-psychotic drugs to people with dementia as they are thought to be associated with up to 1,800 deaths a year.

19 Oct 2012

Study describes design and effectiveness of NIR responsive gold nanorods for chemotherapy

Excitement around the potential for targeted nanoparticles (NPs) that can be controlled by stimulus outside of the body for cancer therapy has been growing over the past few years. More specifically, there has been considerable attention around near-infrared (NIR) light as an ideal method to stimulate nanoparticles from outside the body.

19 Oct 2012

EMA CHMP issues positive opinion to Savient's KRYSTEXXA for treatment of chronic gout

Savient Pharmaceuticals, Inc. and its wholly owned subsidiary, Savient Pharma Ireland Limited, announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has completed its scientific assessment and has issued a positive opinion recommending approval of a marketing authorization in the European Union for KRYSTEXXA for the treatment of severe debilitating chronic tophaceous gout in adult patients who may also have erosive joint involvement and who have failed to normalize serum uric acid with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these medicines are contraindicated.

19 Oct 2012

Carob extracts may combat listeriosis

Leaves of the plant that yields carob - the substitute for chocolate that some consider healthier than chocolate - are a rich source of antibacterial substances ideal for fighting the microbe responsible for listeriosis, a serious form of food poisoning, according to a report in ACS' Journal of Agricultural and Food Chemistry.

19 Oct 2012

Two Chicago students develop novel treatment method for fetal alcohol syndrome

Two Chicago high school students have developed a novel treatment method to reduce the negative effects of Fetal Alcohol Syndrome (FAS) and a new understanding of genetics behind the disease.

19 Oct 2012

Novel C-substituted diindolylmethane shows promise against triple-negative breast cancer

A new compound created from a rich source in vegetables including broccoli and brussel sprouts has been developed to combat triple-negative breast cancer (TNBC).

19 Oct 2012

Minnelide gives new hope for patients with pancreatic cancer

A new drug created at the University of Minnesota may hold the answer to defeating pancreatic cancer, according to results published today in the prestigious journal Science Translational Medicine.

19 Oct 2012

ThromboGenics receives FDA approval for Jetrea to treat symptomatic vitreomacular adhesion

On Oct. 17, the U.S. Food and Drug Administration approved Jetrea (ocriplasmin), the first drug approved to treat an eye condition called symptomatic vitreomacular adhesion (VMA).

19 Oct 2012

Liver x receptor plays an important role in diabetic nephropathy

Researchers have discovered a new therapeutic target for diabetic nephropathy, the leading cause of kidney failure.

19 Oct 2012

BioResearch Open Access explores Cell-SELEX technology

SELEX is a rapid, efficient, and iterative high-throughput method for screening large libraries of molecules to identify those with the potential to be developed as drug compounds or research tools. Advances in SELEX technology that have enabled screening in live cells, called Cell-SELEX, are explored in a comprehensive Review article published in BioResearch Open Access, a bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc.

19 Oct 2012

Roundup: Ore. lawmakers petition for separate dental care; Docs failing to check drug registry in Colo.

The state is inviting public comment on how dentists fit with reforms of the Oregon Health Plan. Last week, two lawmakers and a dental executive submitted a petition to the Oregon Health Authority asking that dental care remain separate until 2017 from the state's new coordinated care organizations (CCOs), provider networks set up to integrate services, manage spending and reward prevention in the care of low-income members of the Medicaid-funded system.

19 Oct 2012

Federal agents raid drug compounding center

Food and Drug Administration investigators probe the Massachusetts pharmacy linked to a meningitis outbreak that has killed 16.

19 Oct 2012

Antidepressant use may increase risk of strokes caused by bleeding in the brain

Research shows that use of popular antidepressants is linked to an increased risk of some strokes caused by bleeding in the brain, but that the risk is low, according to a multi-study analysis published in the October 17, 2012, online issue of Neurology®, the medical journal of the American Academy of Neurology.

19 Oct 2012